Marketing IVDs (in vitro diagnostics) in Japan becomes ever more complex as economic stagnation hits health spending
This article was originally published in Clinica
Japan has always been a difficult market for an in vitro diagnostic company to crack. But the economic recession and the resulting need for the government to limit medical spending is creating new complications for the industry. Karen Riley reports from a conference in Chicago on International Regulatory and Reimbursement Strategies for IVDs.